Concepedia

Vahak Abedi

VA

Statistics

Publications

5

Citations

365

H-Index

5

Active since

2002

Affiliations

AstraZeneca (Sweden)(Current)

KTH Royal Institute of Technology

AstraZeneca (United Kingdom)

Stockholm University

Vahak Abedi is an author at AstraZeneca (Sweden) specializing in life sciences, enzymology, and molecular biology.

Publications per year

2002–2012

5

Publications

5

Transaminations with isopropyl amine: equilibrium displacement with yeast alcohol dehydrogenase coupled to in situ cofactor regeneration

Karim Engelmark Cassimjee, Cecilia Branneby, Vahak Abedi et al. · Chemical Communications · 2010 · 131 citations

Life Sciences, Molecular Biology, Enzyme Technology +10

Crystal structures of the <i>Chromobacterium violaceum</i>ω‐transaminase reveal major structural rearrangements upon binding of coenzyme PLP

Maria Svedendahl Humble, Karim Engelmark Cassimjee, M. Håkansson et al. · FEBS Journal · 2012 · 123 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Chromobacterium violaceum ω-transaminase variant Trp60Cys shows increased specificity for (S)-1-phenylethylamine and 4′-substituted acetophenones, and follows Swain–Lupton parameterisation

Karim Engelmark Cassimjee, Maria Svedendahl Humble, Henrik Land et al. · Organic & Biomolecular Chemistry · 2012 · 50 citations

Life Sciences, Biochemistry, Molecular Biology +17

Key Amino Acid Residues for Reversed or Improved Enantiospecificity of an ω‐Transaminase

Maria Svedendahl Humble, Karim Engelmark Cassimjee, Vahak Abedi et al. · ChemCatChem · 2012 · 49 citations

Life Sciences, Biochemistry, Biotechnology +17

Frakefamide, an Analgesic Tetrapeptide: Development of a Pilot-Plant-Scale Process

Henry M. Franzén, Galina Bessidskaia, Vahak Abedi et al. · Organic Process Research & Development · 2002 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 5